# Dehydroepiandrosterone Versus Growth Hormone in Women Undergoing ICSI With Expected Poor Ovarian Response

> **NCT02736591** · PHASE3 · UNKNOWN · sponsor: **Cairo University** · enrollment: 210 (estimated)

## Conditions studied

- Subfertility

## Interventions

- **DRUG:** DHEA
- **DRUG:** Growth Hormone-Releasing Hormone
- **DRUG:** Placebo 1
- **DRUG:** Placebo 2

## Key facts

- **NCT ID:** NCT02736591
- **Lead sponsor:** Cairo University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-06
- **Primary completion:** 2017-04
- **Final completion:** —
- **Target enrollment:** 210 (ESTIMATED)
- **Last updated:** 2016-07-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02736591

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02736591, "Dehydroepiandrosterone Versus Growth Hormone in Women Undergoing ICSI With Expected Poor Ovarian Response". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02736591. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*